CTech 24/7
- “Whatever means necessary”: Deel alleges Rippling ran coordinated espionage campaign
- Intel Products CEO: “Employees are very optimistic about the fact that Lip-Bu can help us”
- For digital bank One Zero, AI is “a central growth engine”
- Amdocs on AI: “We simply cannot adopt every new solution that emerges”
More stories in CTechLife Sciences
25 stories about Life Sciences
Investments in Israeli life sciences companies drops 40% to $1.4 billion in H1 of 2023
Dot Compliance raises $23 million Series B for life science quality and compliance platform
Prepare for a year of M&As in Israeli life sciences companies
"Every CEO needs to have a good grasp on social psychology because having that human-to-human connection is crucial"
Chinese VC RunYoung launches $50 million fund to invest in Israeli life science startups
Peregrine Ventures launches $300 million life science fund
You can’t sit and wait for life-science startups to come to you, you have to create them
Israel is in a great position to capitalize on the rapid rise of medtech, says veteran investor
Roche, aMoon to launch early-stage innovation program
Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert
Life Sciences Venture Fund aMoon Raises $600 Million for Second Fund, Report Says
Life Sciences Venture Fund aMoon Nearing Cap of Second Fund, Says Co-Founder
Israel to Help Biotech Companies Go from Research to Manufacturing
Jerusalem-Based Shavit Capital Raises $100 Million for Fifth Fund
31.10.18The Israeli venture capital firm specializes in late-stage life sciences investments
LR Group Wins Jerusalem Tender for $130 Million Life Sciences Fund
Microsoft, Google to Battle Israeli Court Tax Decision
At Swiss Pharma Company, Women’s Health Gets Personal
Ben Gurion University Launches $1 Million Investment Fund
CTech’s Weekly Roundup of Israeli Tech News
Credit Suisse to Invest $250 Million in Israel-based Life Sciences Venture Fund aMoon
Load more
